Article

Predictors of Extrapyramidal Side Effects among Patients Taking Antipsychotic Medication at Mekelle Psychiatry Units, Northern Ethiopia, 2023: Unmatched Case-Control Study

2024-01-12

Abstract excerpt

<title>Abstract</title> <p>Background Schizophrenia is one of the most disruptive of neuropsychiatric disorders, affecting around 1% of the world's population. Antipsychotic medications have been the backbone of schizophrenia treatment for the past 50 years. Extrapyramidal side effects of antipsychotic medication are a major problem which is associated with various factors. However, there is a dearth of evidence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 37d2c484-675f-5e77-b5ae-a6388ffcdfbc
DOI: 10.21203/rs.3.rs-3849507/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predictors of Extrapyramidal Side Effects among Patients Taking Antipsychotic Medication at Mekelle Psychiatry Units, Northern Ethiopia, 2023: Unmatched Case-Control StudyDOI 10.21203/rs.3.rs-3849507/v1Read

Factors associated with extrapyramidal side effects of first-generation antipsychotics: a cross- sectional study in Ugandan tertiary hospitalsSemantic proximity Read

Prevalence and associated factors of Tardive dyskinesia among psychiatric patients on first-generation antipsychotics at Jimma University specialized hospital, psychiatric clinic, Ethiopia: Institution based a cross-sectional studySemantic proximity Read

Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia.Semantic proximity Read

Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene StudySemantic proximity Read

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity Read

[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].Semantic proximity Read

Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.Semantic proximity Read

Examining side effect variation in antipsychotic treatment and schizophrenia spectrum disordersSemantic proximity Read

Impact of ABCB1 (rs1045642) polymorphism on antipsychotic-induced extrapyramidal symptoms in Egyptian patients with schizophrenia.Semantic proximity Read

Pharmacogenetics of antipsychotic-induced side effects.Semantic proximity Read

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity Read